丝裂原活化蛋白激酶信号通路在非小细胞肺癌中作用的研究进展

被引：7

作者：

周宇辉 ^{[1
]}

詹瑧 ^{[1
]}

唐于平 ^{[2
]}

段金廒 ^{[2
]}

张旭 ^{[1
,2
]}

机构：

[1] 南京中医药大学基础医学院中西医结合基础学科

[2] 江苏省方剂研究重点实验室

来源：

中国肺癌杂志 | 2009年 / 12卷 / 09期

关键词：

小细胞肺癌; 亚族; NSCLC; 丝裂原活化蛋白激酶; 信号通路; MAPKs; 肺癌细胞;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100214 ;

摘要：

<正>肺癌是当今世界上严重威胁人类健康与生命的恶性肿瘤,发病率在多数国家呈明显增高趋向,全球每年有超过100万人死于肺癌,约85%为非小细胞肺癌(Non-

引用

页码：1036 / 1040

页数：5

共 12 条

[1] Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway [J].

Chou, Teh-Ying ;

Chen, Wei-Chieh ;

Lee, An-Chieh ;

Hung, Su-Mei ;

Shih, Neng-Yao ;

Chen, Mei-Yu .

CELLULAR SIGNALLING, 2009, 21 (05) :704-711

[2] PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer [J].

Ming, Jian ;

Liu, Nan ;

Gu, Yumei ;

Qiu, Xueshan ;

Wang, En-Hua .

PATHOLOGY, 2009, 41 (02) :118-126

[3] Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression [J].

Serini, Simona ;

Trombino, Sonia ;

Oliva, Francesco ;

Piecioni, Elisabetta ;

Monego, Giovanni ;

Resci, Federica ;

Boninsegna, Alma ;

Picci, Nevio ;

Ranelletti, Franco Oreste ;

Calviello, Gabriella .

APOPTOSIS, 2008, 13 (09) :1172-1183

[4]

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship[J] . Julian R. Molina,Ping Yang,Stephen D. Cassivi,Steven E. Schild,Alex A. Adjei.Mayo Clinic Proceedings . 2008 (5)

[5] A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation [J].

Jina, Hyeon-Ok ;

Seo, Sung-Keum ;

Woo, Sang-Hyeok ;

Lee, Hyung-Chahn ;

Kim, Eun-Sung ;

Yoo, Doo-Hyun ;

Lee, Su-Jae ;

An, Sungkwan ;

Choe, Tae-Boo ;

Kim, Jong-Il ;

Hong, Seok-Il ;

Rhee, Chang-Hun ;

Park, In-Chul .

LUNG CANCER, 2008, 61 (03) :317-327

[6] Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics [J].

Cragg, Mark S. ;

Kuroda, Junya ;

Puthalakath, Hamsa ;

Huang, David C. S. ;

Strasser, Andreas .

PLOS MEDICINE, 2007, 4 (10) :1681-1690

[7]

Role of Raf Kinase in Cancer: Therapeutic Potential of Targeting the Raf/MEK/ERK Signal Transduction Pathway[J] . Jared A. Gollob,Scott Wilhelm,Chris Carter,Susan L. Kelley.Seminars in Oncology . 2006 (4)

[8] Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells [J].